From:
`To:
`Cc:
`
`Subject:
`Date:
`
`Trials
`GQuillin@foley.com; Trials
`Mathas, Kurt A. (KMathas@winston.com); Sommer, Andrew R.; MNutter@winston.com; Johannes, Tyler G.;
`ssnader@unither.com; vascarrunz@wsgr.com; dcarsten@wsgr.com; bdelafield@wsgr.com; rtorczon@wsgr.com;
`SMaebius@foley.com; NIyer@foley.com; wjackson@bsfllp.com
`RE: Watson Labs. v. UTC, IPR2017-01621, -01622; request for conference call
`Wednesday, June 20, 2018 5:36:29 PM
`
`Counsel:  On Friday June 15, 2018, Patent Owner requested a teleconference to address two issues:
`1) the scheduling and location of four non-party fact witness depositions, and 2) reliance in Patent
`Owner’s post-SAS Supplemental Response on arguments previously presented in Patent Owner’s
`Response.  Pursuant to this request a teleconference was held on Wednesday, June 20, 2018,
`wherein both parties had the opportunity to address the panel.
` 
`With respect to the first issue, the parties have been unable to agree upon a location for the
`depositions of Drs. Ghofrani, Grimminger, Reichenberger, and Seeger, four non-party fact witnesses
`located in Germany.  Both parties stressed that resolution of this issue was time sensitive,
`representing that scheduling the depositions would require substantial lead time.  In recognition of
`the time-sensitive nature of this issue, we are notifying the parties of our decision by email.  We will
`issue an Order explaining the basis of our decision in due course.  After carefully considering the
`arguments presented by both parties, we authorize the depositions of Drs. Ghofrani, Grimminger,
`Reichenberger, and Seeger to occur in Germany or, in the event depositions in Germany prove
`impracticable, in such other European country as is mutually agreeable to the parties and the
`witnesses.  The parties are encouraged to work together to minimize inconvenience to the parties
`and to the witnesses.  The parties are further encouraged to modify scheduling deadlines as
`contemplated in the Scheduling Order if necessary to accommodate these depositions.   
` 
`With respect to the second issue, the panel agreed that Patent Owner may, in its post-SAS
`Supplemental Patent Owner Response, refer back to arguments raised in the Patent Owner
`Response. 
` 
`Thank you,
` 
`Maria Vignone
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`703-756-1288
` 
` 
` 
` 
`From: GQuillin@foley.com <GQuillin@foley.com> 
`Sent: Friday, June 15, 2018 2:45 PM
`To: Trials <Trials@USPTO.GOV>
`Cc: Mathas, Kurt A. (KMathas@winston.com) <KMathas@winston.com>; Sommer, Andrew R.
`<ASommer@winston.com>; MNutter@winston.com; Johannes, Tyler G.
`<Tjohannes@winston.com>; ssnader@unither.com; vascarrunz@wsgr.com; dcarsten@wsgr.com;
`
`

`

`bdelafield@wsgr.com; rtorczon@wsgr.com; SMaebius@foley.com; NIyer@foley.com;
`wjackson@bsfllp.com
`Subject: Watson Labs. v. UTC, IPR2017-01621, -01622; request for conference call
`
`Dear Board:
` 
`Patent Owner requests a telephone conference to address two separate issues.  First, the parties
`have been unable to reach agreement on the scheduling and location of four non-party fact
`witnesses located in Germany and request a call with the Board for guidance.  Second, Patent Owner
`requests clarity regarding the reference and reliance in its post-SAS Supplemental Response on
`arguments previously presented in Patent Owner’s Response. 
` 
`The parties are available for a conference call on Tuesday June 19th any time after 2:30 pm ET or 
`Wednesday June 20th any time except 2-4 pm ET.  The Patent Owner will provide a court reporter. 
`Counsel for Petitioner is copied on this email.
` 
`Best regards,
` 
`George E. Quillin
`Back up counsel for Patent Owner
` 
`
`The preceding email message may be confidential or protected by the attorney-client or work-
`product privileges. It is not intended for transmission to, or receipt by, any unauthorized
`persons. If you have received this message in error, please (i) do not read it, (ii) reply to the
`sender that you received the message in error, and (iii) erase or destroy the message and any
`attachments or copies. Any disclosure, copying, distribution or reliance on the contents of this
`message or its attachments is strictly prohibited, and may be unlawful. Unintended
`transmission does not constitute waiver of the attorney-client privilege or any other privilege.
`Legal advice contained in the preceding message is solely for the benefit of the Foley &
`Lardner LLP client(s) represented by the Firm in the particular matter that is the subject of this
`message, and may not be relied upon by any other party. Unless expressly stated otherwise,
`nothing contained in this message should be construed as a digital or electronic signature, nor
`is it intended to reflect an intention to make an agreement by electronic means.
`
`